In cancer stem cells, high doses of IFNγ inhibit self-renewal and induce apoptosis of colon cancer cell lines78, whereas low doses of IFNγ potentiate the stemness of non-small cell lung cancer-derived cell lines, as well as dormancy in melanoma and breast cancer79,80. Here, IFNG is linked to non-small cell lung carcinoma.